| NEW! REVIEWS Based on your feedback, we’ve added a Reviews section to Prostate Cell News | The Reactive Stroma Microenvironment and Prostate Cancer Progression This review discusses the co-evolution of reactive stroma and the biology of how reactive stroma-carcinoma interactions regulate cancer progression and metastasis are targets for new therapeutic approaches. [Endocr Relat Cancer] Abstract |
| INDUSTRY NEWS | U.S. FDA Grants Priority Review Of ZYTIGA® (Abiraterone Acetate) sNDA For Treatment of Metastatic Castration-Resistant Prostate Cancer before Chemotherapy Janssen Research & Development, LLC, announced that the U.S. Food and Drug Administration (FDA) has granted priority review to the supplemental new drug application (sNDA) for ZYTIGA® administered in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy. [Johnson & Johnson Family of Companies] Press Release The Maryland Stem Cell Research Commission: Public Statement The Maryland Stem Cell Research Commission is pleased with the opinion issued by the U.S. Court of Appeals for the District of Columbia Circuit in Sherley, et al. vs. Sebelius, et al. regarding the federal funding of human embryonic stem cell research. The position taken by the Court allows this promising stem cell research to progress in the U.S., paving the way for groundbreaking discoveries that could ameliorate a multitude of debilitating diseases and disorders. [Maryland Stem Cell Research Fund, United States] Press Release |
|
|
|